Clinical Trial Update: A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A phase 3 open-label pilot trial evaluating memantine as augmentation therapy for generalized anxiety disorder and social anxiety disorder, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Social Anxiety Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: General Anxiety Disorder, Social Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-12-10